Skip to main content

Advertisement

Log in

Prognostic Factors in Primary Vaginal Cancer: A Single Institute Experience and Review of Literature

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Background

Primary vaginal carcinoma is rare, accounting for 1–2 % of all gynecological malignancies. Being rare, most observations are based on retrospective and comparative analyses. This study was aimed to retrospectively analyze the prognostic factors and its relevance in the outcomes of primary vaginal cancers.

Materials

Medical records of all cases of primary vaginal cancers, presented to Department of Oncology, from 2004 to 2012, at a tertiary care center in southern India, were retrieved from electronic medical records, and were analyzed.

Results

The total number of cases was 32. Median age at presentation was 64.28 years. Squamous histology accounted for 84.4 %, with the rest being adenocarcinoma. Surgery was offered for five (15.6 %), and concurrent chemotherapy for 14 (43.8 %) patients. Three patients had only surgery. All others received radiotherapy. Twenty received external beam radiation (EBRT) and vaginal brachytherapy (VBT); seven only EBRT and two, adjuvant radiation. Five patients had residual disease; two, stage III, and three stage IV. Median follow-up was 55.83 months. Twelve patients were alive at last follow-up (37.5 %), while 14 were dead (43.8 %—8 of disease and 6 of other causes). Six patients were lost to follow-up (18.8 %). Twenty patients were disease free. Seven had recurrence, three loco-regional and four distant. Median overall survival (OS) was 86.1 months, disease-free survival (DFS) 90.17 months, and disease-specific survival (DSS) 97.13 months. When well and moderately differentiated tumors were taken together, the 5-year OS, DFS, and DSS rates were, 56.6, 64.3, and 82.3 %. For poorly differentiated tumors, median OS, DFS, and DSS were, 20.9, 14.6, and 20.9 months, with statistically significant advantage for better grade tumors, for DSS (p 0.050). Better 5-year OS, DFS, and DSS rates were observed for stage I + II group, with 54.9, 79.8, and 78.9 %, compared with advanced stage where the same were 54.8, 38.2, and 68.6 % (DFS—p 0.003, DSS—p 0.009). Grade and stage of tumor had statistically significant predictive value over the outcomes, while tumor size showed a significant trend. Patients treated with combination of EBRT and VBT fared well.

Conclusion

Our study could conclude that grade of differentiation was a significant predictor of poor survival as was stage of disease. Combination of VBT and external beam radiotherapy provides good DFS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Di Donato V, Bellati F, Fischeti M, et al. Vaginal cancer. J Crit Rev Oncol/Hematol. 2012;81:286–95.

    Article  Google Scholar 

  2. Taussig FJ. Primary cancer of the vulva, vagina and female urethra: 5 year results. Surg Gynecol Obstet. 1935;60:477–88.

    Google Scholar 

  3. Stryker JA. Radiotherapy for vaginal carcinoma: a 23-year review. Br J Radiol. 2000;73:1200–5.

    Article  CAS  PubMed  Google Scholar 

  4. Kosary CL. Cancer of the vagina. In: Ries LA, Young JL, Keel GE, et al (eds.). SEER survival monographs: cancer survival among adults: U.S.Seer Program, 1988 [NIH Pub.No07-6215]. Bethesda (MD): National Cancer Institute; 2007. p. 155–160.

  5. Lian J, Dundas G, Carlone M, et al. Twenty year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol. 2008;111:298–306.

    Article  PubMed  Google Scholar 

  6. Chyle V, Zagras GK, Wheeler JA, et al. Definitive radiotherapy for carcinoma of the vagina: outcomes and prognostic factors. Int J Radiat Oncol Biol Phys. 1996;35(5):891–905.

    Article  CAS  PubMed  Google Scholar 

  7. Frank SJ, Jhingran A, Levenback C, et al. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005;62(1):138–47.

    Article  PubMed  Google Scholar 

  8. Platta CS, Anderson B, Geye H, et al. Adjuvant and definitive radiation therapy for primary carcinoma of the vagina using brachytherapy and external beam radiation therapy. J Contemp Brachytherapy. 2013;5(2):76–82.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Miyamoto DT, Viswanathan AN. Concurrent chemoradiation for vaginal cancer. PLoS One. 2013;8(6):e65048.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Creasman WT, Phillips JL, Meneck HR. The national cancer data base report on cancer of the vagina. Cancer. 1998;83(5):1033–40.

    Article  CAS  PubMed  Google Scholar 

  11. Hellman K, Lundell M, Silfversward C, et al. Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer. 2006;16(3):1201–11.

    Article  CAS  PubMed  Google Scholar 

  12. Hiniker SM, Roux A, Murphy JD, et al. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol. 2013;131:380–5.

    Article  PubMed  Google Scholar 

  13. Fleming P, Syed AMN, Neblett D, et al. Description of an after-loading Ir-192 interstitial-intra-cavitary technique in the treatment of carcinoma of the vagina. Obstet Gynecol. 1980;55:525–30.

    CAS  PubMed  Google Scholar 

  14. Kirkbride P, Fyles A, Rawlings GA, et al. Carcinoma of the vagina—experience at the Princess Margaret Hospital (1974–1989). Gynecol Oncol. 1995;56:435–43.

    Article  CAS  PubMed  Google Scholar 

  15. Kucera H, Vavra N. Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol. 1991;40:12–6.

    Article  CAS  PubMed  Google Scholar 

  16. Ali MM, Huang DT, Howels R, et al. Radiation alone for carcinoma of vagina: variation in response related to the location of the primary tumor. Cancer. 1996;77:1934–9.

    Article  CAS  PubMed  Google Scholar 

  17. Perez CA, Grigsby PW, Garipagaoglu M, et al. Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 1999;44:37–45.

    Article  CAS  PubMed  Google Scholar 

  18. Jang WI, Wu HG, Ha SW, et al. Definitive radiotherapy for treatment of primary vaginal cancer: effectiveness and prognostic factors. Int J Gynecol Cancer. 2012;22(3):521–7.

    Article  PubMed  Google Scholar 

  19. Kucera H, Mock U, Knocke TH, et al. Radiotherapy alone for invasive vaginal cancer: outcome with intra-cavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstet Gynecol Scand. 2001;80(4):355–60.

    Article  CAS  PubMed  Google Scholar 

  20. Murakami N, Kasamatsu T, Sumi M, et al. Radiation therapy for primary vaginal carcinoma. J Radiat Res. 2013;54(5):931–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Miyamoto DT, Tanaka CK, Viswanathan AN. Concurrent chemoradiation improves survival in patients with vaginal cancer. Int J Radiat Oncol Biol Phys. 2010;10(3):s120 (abstract).

    Article  Google Scholar 

  22. Miyamoto DT, Viswanathan AN. Concurrent chemoradiation for vaginal cancer. PLoS One. 2013;8(6):e65048.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ghia AJ, Gonzalez VJ, Tward JD, et al. Primary vaginal cancer and chemoradiotherapy: a pattern-of-care analysis. Int J Gynecol Cancer. 2011;21(2):378–84.

    Article  PubMed  Google Scholar 

  24. Blecharz P, Reinfuss M, Jakubowicz J, et al. Radiation therapy complications in patients with primary invasive vaginal carcinoma. Ginekol Pol. 2013;84(3):206–10.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethical Requirements and Conflict of Interest

This is a retrospective analysis of all cases of primary vaginal cancers presented to our tertiary care institute from 2004 to 2012. Hence no ethical issues were involved. No conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chelakkot G. Prameela.

Additional information

Dr. Chelakkot G. Prameela is an Associate Professor at Amrita Institute of Medical Sciences; Dr. Rahul Ravind is a Resident at Amrita Institute of Medical Sciences; Dr. Bharath C. Gurram is a Resident at Amrita Institute of Medical Sciences; Ms. V. S. Sheejamol is a Lecturer at Amrita Institute of Medical Sciences; and Dr. Makuny Dinesh is a Professor at Amrita Institute of Medical Sciences.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prameela, C.G., Ravind, R., Gurram, B.C. et al. Prognostic Factors in Primary Vaginal Cancer: A Single Institute Experience and Review of Literature. J Obstet Gynecol India 66, 363–371 (2016). https://doi.org/10.1007/s13224-015-0697-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-015-0697-6

Keywords

Navigation